Journal of Gynecologic Oncology
Scope & Guideline
Leading the Charge in Gynecologic Cancer Research
Introduction
Aims and Scopes
- Ovarian Cancer Management:
Research and clinical guidelines focusing on the treatment, surgery, and management of ovarian cancers, including the use of novel therapies like PARP inhibitors and surgical techniques. - Cervical Cancer Research:
A significant focus on cervical cancer, including screening, treatment protocols, and innovative surgical techniques, highlighting the importance of early detection and effective management. - Endometrial Cancer Studies:
In-depth studies on endometrial cancer, including prognostic factors, molecular classifications, and the development of treatment guidelines for various stages of the disease. - Minimally Invasive Surgical Techniques:
Exploration and clinical evaluation of minimally invasive surgical approaches in gynecologic oncology, including robotic surgeries and laparoscopic methods, aimed at improving patient outcomes. - Immunotherapy and Precision Medicine:
Investigation of immunotherapeutic strategies and the application of precision medicine in treating gynecologic cancers, underscoring the shift towards personalized treatment plans. - Epidemiology and Outcomes Research:
Analysis of epidemiological trends and patient outcomes in gynecologic cancers, contributing to a better understanding of risk factors and treatment efficacy.
Trending and Emerging
- PARP Inhibitor Research:
Increased focus on PARP inhibitors and their role in managing ovarian cancer, particularly in frontline maintenance therapies and overcoming resistance, showcasing a significant shift in treatment paradigms. - Guideline Development and Standardization:
Emerging trends in the formulation of clinical guidelines by various oncology societies, indicating a collaborative approach to standardizing care and improving treatment outcomes across regions. - Integration of Genetic and Molecular Profiling:
A rising emphasis on genetic and molecular profiling in diagnosing and treating gynecologic cancers, paving the way for tailored therapies that enhance patient management. - Self-Sampling Techniques for HPV Testing:
Growing interest in self-sampling methods for HPV testing, particularly in low-resource settings, as part of broader initiatives to improve cervical cancer screening access. - Prognostic Biomarkers and Models:
An emerging focus on developing and validating prognostic models and biomarkers that can predict treatment responses and patient outcomes, facilitating personalized medicine.
Declining or Waning
- Traditional Chemotherapy Approaches:
There is a noticeable decline in studies focusing solely on traditional chemotherapy regimens, as newer targeted therapies and immunotherapies gain precedence in treatment discussions. - Basic Surgical Techniques:
Research concentrating on basic surgical techniques is waning as more emphasis is placed on advanced minimally invasive and robotic surgeries that enhance recovery and outcomes. - General Screening Practices:
While screening remains critical, there is a shift away from general screening practices towards more specific and targeted screening methods, particularly involving HPV and personalized risk assessments. - Longitudinal Studies on Older Treatment Protocols:
Fewer publications focus on older treatment protocols that have been largely replaced by newer, more effective strategies, indicating a transition towards contemporary practices.
Similar Journals
INTERNATIONAL SURGERY
Elevating Standards in Surgical Education and PracticeINTERNATIONAL SURGERY, published by the International College of Surgeons, is a vital resource in the field of surgical medicine, with an ISSN of 0020-8868. Established in 1966, this journal serves as a platform for researchers and practitioners to share innovative surgical techniques, critical studies, and reviews that shape the future of surgical practices worldwide. Although it currently resides in the Q4 category of Surgery for 2023, the journal is committed to fostering the dissemination of knowledge, urging authors to contribute to its growth and influence. Situated in the United States at 1516 N Lake Shore Dr, Chicago, IL 60610, INTERNATIONAL SURGERY aims to bridge the gap between emerging surgical trends and clinical application. While it does not offer open access options, the journal's archives are a treasure trove of wisdom for both seasoned professionals and students who seek to deepen their understanding of the surgical domain. Join us in exploring the challenges and advancements within surgery, as we work towards enhancing patient care and surgical outcomes.
Journal of Gastrointestinal Oncology
Connecting experts to tackle gastrointestinal oncology challenges.The Journal of Gastrointestinal Oncology, published by AME Publishing Company, is a leading open-access journal that focuses on the complex interplay between gastroenterology and oncology. Established in 2012 and converging into a reputable academic platform through 2024, the journal serves as a vital resource for researchers, clinicians, and students interested in the latest advancements in the diagnosis, treatment, and management of gastrointestinal cancers. With an ISSN of 2078-6891 and an E-ISSN of 2219-679X, this journal presents articles that are rigorously peer-reviewed, ensuring high-quality content that meets the demands of the scientific community. Despite its current categorization in the Q3 quartile for both Gastroenterology and Oncology as of 2023, it consistently strives to improve its impact and relevance, reflected in its Scopus rankings and percentile metrics. Publishing noteworthy research, reviews, and case studies, the Journal of Gastrointestinal Oncology is instrumental in addressing significant challenges in the field, making it a must-read for those dedicated to advancing knowledge and practice in gastrointestinal oncology.
Gynecology and Minimally Invasive Therapy-GMIT
Exploring the future of obstetrics with groundbreaking research.Gynecology and Minimally Invasive Therapy (GMIT) is a distinguished open-access journal published by Wolters Kluwer Medknow Publications, focused on advancing the field of obstetrics and gynecology through innovative research and insights into minimally invasive techniques. With an ISSN of 2213-3070 and E-ISSN 2213-3089, GMIT has established itself as a prominent platform for researchers and clinicians alike, facilitating the dissemination of pivotal findings since its inception in 2012. The journal currently ranks in the Q3 category for Obstetrics and Gynecology in 2023, with a Scopus ranking of #120/209, placing it in the 42nd percentile within its field. Based in Mumbai, India, it has embraced open access since 2016, promoting the wide availability of groundbreaking research to enhance clinical practices and improve patient outcomes. GMIT aims to foster knowledge sharing and interdisciplinary collaboration, vital for professionals in the rapidly evolving landscape of gynecological care.
Indian Journal of Urology
Fostering Collaboration and Innovation in Urology.Indian Journal of Urology, published by Wolters Kluwer Medknow Publications, is a premier open-access journal dedicated to the field of urology, serving as a vital platform for researchers and clinicians to disseminate groundbreaking findings since its inception in 2001. With an ISSN of 0970-1591 and an E-ISSN of 1998-3824, this journal has established itself as a crucial resource for advancing knowledge in urological practices, particularly within the Indian context. Recognized in the 2023 Scopus Rankings with a classification of Q3 in Urology, it stands at a significant position (Rank #71 out of 120) with a 41st percentile performance, highlighting its role in contributing to the global discourse in urological medicine. The journal provides open access options, ensuring that high-quality research is readily available to a broad audience, fostering collaboration and innovation. Publishing significant studies from various converged years, including from 1984 to 1999 and more recently from 2006 to 2024, Indian Journal of Urology is essential for professionals seeking to stay updated with the latest advances and best practices in urology.
Journal of Visceral Surgery
Transforming Visceral Surgery Through Innovative StudiesThe Journal of Visceral Surgery, an esteemed publication from Elsevier Masson, offers a crucial platform for disseminating innovative research in the field of visceral surgery. Operating since 2010 and continually evolving through to 2024, this journal is dedicated to presenting high-quality studies and clinical findings that advance the practice and understanding of surgical techniques and patient care in visceral surgery. With an ISSN of 1878-7886 and a notable impact within the academic community, it achieved a Q2 ranking in Medicine (miscellaneous) and a Q3 ranking in Surgery as of 2023, reflecting its growing influence in the surgical domain. Although it currently does not operate under an Open Access model, the journal remains committed to informing a diverse audience of scholars, practitioners, and students about pioneering methods, case studies, and reviews within the discipline. Positioned in France, the journal serves as an indispensable resource for enhancing surgical practice and fostering collaboration among professionals globally, making it a vital read for anyone invested in the advancement of visceral surgery.
Current Urology
Your Resource for Cutting-Edge Urological ResearchCurrent Urology, published by Lippincott Williams & Wilkins, is a leading journal dedicated to advancing the fields of urology, oncology, and reproductive medicine. With an ISSN of 1661-7649 and E-ISSN of 1661-7657, this journal has established itself as a valuable resource for researchers, practitioners, and students alike, providing peer-reviewed articles that contribute to the ongoing discourse and development of these critical specialties. Operating out of the United States, Current Urology ranks in the third quartile for oncology, reproductive medicine, and urology, reflecting its importance in the medical community. The journal’s focus on innovative research and clinical practice allows it to bridge gaps between theoretical understanding and practical application, enhancing patient care and outcomes. Although currently not an open-access journal, it offers a wealth of insights and findings that underpin contemporary urological practices and research. In an evolving medical landscape, Current Urology remains an essential platform for disseminating knowledge and fostering collaboration among experts in the field.
Gynecologic Oncology
Elevating Standards in Women's Health ResearchGynecologic Oncology, an esteemed journal published by Academic Press Inc Elsevier Science, stands at the forefront of research in the domains of Obstetrics and Gynecology and Oncology. With an exceptional track record dating from 1972 to 2024, this journal has established itself as a vital resource for scholars and practitioners alike, boasting a remarkable Q1 ranking in both fields as of 2023. Gynecologic Oncology not only ranks #13 out of 209 in Obstetrics and Gynecology and #72 out of 404 in Oncology but also operates within the top percentiles of academic influence, with a 94th percentile in Obstetrics and Gynecology and an 82nd percentile in Oncology on Scopus. Although the journal does not currently offer open access, it remains crucial for disseminating original research, reviews, and advances in the management and treatment of gynecological cancers. Researchers and health professionals will find this journal indispensable for staying informed on the latest advancements and breakthroughs in this vital area of medicine, fostering a deeper understanding and potentially transforming patient care practices.
Gynecologic Oncology Reports
Connecting scholars to enhance women's health globally.Gynecologic Oncology Reports is a pivotal interdisciplinary journal published by Elsevier Science Inc. that has been dedicated to advancing the understanding of women's health since its inception in 2014. This Open Access journal, available to a global audience, facilitates the dissemination of high-quality research in the fields of gynecology and oncology, allowing for the free exchange of knowledge and fostering collaboration among researchers, clinicians, and students. With an impact factor reflective of its commitment to clinical relevance, Gynecologic Oncology Reports holds a Q3 ranking in both obstetrics and gynecology as well as oncology categories, contributing to its visibility and the prestige of published work. Situated in the Netherlands and operating within an open-access framework, it ensures that critical findings and advancements reach a broad readership. The journal serves as a vital resource for those aiming to stay at the forefront of gynecologic oncology, promoting improved patient outcomes through cutting-edge research. As it converges towards its 10th anniversary in 2024, Gynecologic Oncology Reports continues to be an essential platform for scholarly communication in this important field.
Chinese Journal of Cancer Research
Pioneering insights into cancer biology and treatment.Chinese Journal of Cancer Research, published by Chinese Journal Cancer Research Co, is a pivotal platform for disseminating significant findings in the field of oncology. Since its inception in 1988, the journal has provided a comprehensive forum for cancer research, featuring peer-reviewed articles that cover various aspects of cancer biology, prevention, diagnosis, and treatment. Although the journal's coverage is currently discontinued in Scopus and holds an HIndex that has not been specified, it is ranked in the 65th percentile in Medicine - Oncology and the 48th percentile in Biochemistry, Genetics and Molecular Biology - Cancer Research. This reflects its commitment to maintaining quality and relevance in the rapidly evolving field of cancer research. Researchers, professionals, and students are encouraged to explore its rich archive of studies and breakthroughs to enhance their understanding and further their research. For access, the publication remains instrumental for those invested in advancing the global fight against cancer.
Surgical Oncology Clinics of North America
Innovative Insights for Surgical ExcellenceSurgical Oncology Clinics of North America, published by W B Saunders Co-Elsevier Inc, is a leading journal in the fields of surgical oncology and surgery, captivating readers since its inception in 1995. With ISSN 1055-3207 and E-ISSN 1558-5042, this esteemed journal offers a comprehensive platform for the dissemination of cutting-edge research, clinical studies, and expert reviews pertaining to surgical techniques and oncological advancements. The journal currently holds a commendable Q3 ranking in Oncology and a Q2 ranking in Surgery, underpinned by its impressive Scopus rankings that place it in the top 25% of its category in Medicine, particularly in the surgical domain (Rank #137/551). Although it does not operate under an open-access model, the insights shared within its pages are invaluable for researchers, healthcare professionals, and students dedicated to enhancing patient outcomes in surgical oncology. With a commitment to advancing medical knowledge, Surgical Oncology Clinics of North America remains a crucial resource for those pursuing excellence in surgical practices and oncology treatment methodologies.